Ex-Tesco chief Sir Dave Lewis to head up £45bn GSK consumer spin-off
The IndependentGet the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pharmaceutical giant GlaxoSmithKline has hired former Tesco boss Sir Dave Lewis to chair the consumer healthcare business it plans to spin off next year. The group’s consumer healthcare business – whose brands include Sensodyne toothpaste and Panadol paid relief – is set to demerge from the wide group in “mid 2022” and list separately on the London Stock Exchange. Sir Dave said: “GSK Consumer Healthcare is a world-class business with significant prospects and a high-quality leadership team. “I am looking forward to being part of its exciting future as an independent company and the very positive impact it can have on people’s health all over the world.” GSK chairman Sir Jonathan Symonds said: “I am delighted to welcome Dave as chair-designate of the new consumer healthcare company.
Discover Related
